Second line drug mutation patterns observed among MDR-TB using Genotype MTBDR plus®.

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Stephen Ofori Yirenkyi (14393505) (author)
مؤلفون آخرون:	Osmanu Taufik (21395095) (author), Roger Laryea (21395098) (author), Amanquador Acquah-Keelson (21395101) (author), Japheth Awuletey Opintan (18320072) (author), Gloria Ivy Mensah (9649211) (author)
منشور في:	2025
الموضوعات:	Medicine Genetics Molecular Biology Biotechnology Cancer Science Policy Infectious Diseases Virology provide baseline data however inadequate data greater accra region bactec mgit system aminoglycosides resistance respectively amino acid changes tb drugs using tb control programs 4 %; however predominant mutations associated associated resistant mutations 171 archived isolates 171 isolates came extensively drug resistant tb among mdr male tb patients tb </ p tb patients 4 %) mutations responsible resistant tuberculosis sl </ rrwt2 </ rrs </ rpob </ plus </ katg </ gyramut3a </ gyra </ xlink "> sustained surveillance study sought position 1484 line anti january 2016 impacts negatively genotypic susceptibility genotypic analysis genotype mtbdr december 2020 also determined a90v ), >, mtbdr 9 %). 8 %). 50 %) 5 %) 3 %)
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Second line drug mutation patterns observed among MDR-TB using Genotype MTBDR <i>plus®.</i>